# PfSPZ Vaccine Trial in Malian Children

> **NCT04940130** · PHASE2 · COMPLETED · sponsor: **Sanaria Inc.** · enrollment: 290 (actual)

## Conditions studied

- Malaria
- Malaria,Falciparum

## Interventions

- **BIOLOGICAL:** Sanaria® PfSPZ Vaccine
- **OTHER:** Normal Saline

## Key facts

- **NCT ID:** NCT04940130
- **Lead sponsor:** Sanaria Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-01
- **Primary completion:** 2022-12-10
- **Final completion:** 2022-12-10
- **Target enrollment:** 290 (ACTUAL)
- **Last updated:** 2024-02-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04940130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04940130, "PfSPZ Vaccine Trial in Malian Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04940130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*